Utilization of wireless pH monitoring technologies: A summary of the proceedings from the Esophageal Diagnostic Working Group

Diseases of the Esophagus

Volumn 26, Issue 8, 2013, Pages 755-765

  Richter, J E ^a   Pandolfino, J E ^a   Vela, M F ^a   Kahrilas, P J ^a   Lacy, B E ^a   Ganz, R ^a   Dengler, W ^a   Oelschlager, B K ^a   Peters, J ^a   Devault, K R ^a   Fass, R ^a   Gyawali, C P ^a   Conklin, J ^a   Demeester, T ^a  

^a Digestive Disease Week 2011   (United States)

Author keywords

Impedance; PH; Reflux monitoring

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ARTICLE; BILE REFLUX; EOSINOPHILIC ESOPHAGITIS; ESOPHAGEAL MOTOR DISORDER; ESOPHAGUS ACHALASIA; ESOPHAGUS DISEASE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; PATIENT MONITORING; PH MEASUREMENT; PRIORITY JOURNAL; STOMACH PARESIS; THORAX PAIN; TREATMENT RESPONSE;

IMPEDANCE; PH; REFLUX MONITORING;

ADVISORY COMMITTEES; ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGEAL PH MONITORING; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; PROTON PUMP INHIBITORS; WIRELESS TECHNOLOGY;

EID: 84887618934     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2012.01384.x     Document Type: Article

References (42)

1. Vakil N, van Zanten S V, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101 (8): 1900-20. quiz 43.
2. Vaezi M F, Richter J E. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996; 111 (5): 1192-9.
3. Avidan B, Sonnenberg A, Schnell T G, Sontag S J. Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Dig Dis Sci 2002; 47 (2): 256-64.
4. Campos G M, Peters J H, DeMeester T R etal. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999; 3: 292-300.
5. Khajanchee Y S, Hong D, Hansen P D, Swanstrom L L. Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results. Am J Surg 2004; 187 (5): 599-603.
6. Taghavi S A, Ghasedi M, Saberi-Firoozi M etal. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 2005; 54 (8): 1067-71.
7. Slaughter J C, Goutte M, Rymer J A etal. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2011; 9 (10): 868-74.
8. Wiener G J, Morgan T M, Copper J B etal. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 1988; 33 (9): 1127-33.
9. Weusten B L, Roelofs J M, Akkermans L M, Van Berge-Henegouwen G P, Smout A J. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107 (6): 1741-5.
10. Singh S, Richter J E, Bradley L A, Haile J M. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci 1993; 38 (8): 1402-8.
11. Bredenoord A J, Weusten B L, Timmer R, Conchillo J M, Smout A J. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol 2006; 101 (3): 453-9.
12. Mainie I, Tutuian R, Shay S etal. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55 (10): 1398-402.
13. Agrawal A, Tutuian R, Hila A, Freeman J, Castell D O. Ingestion of acidic foods mimics gastroesophageal reflux during pH monitoring. Dig Dis Sci 2005; 50 (10): 1916-20.
14. Vela M F, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz P O, Castell D O. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001; 120 (7): 1599-606.
15. Sifrim D, Holloway R, Silny J, Tack J, Lerut A, Janssens J. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001; 96 (3): 647-55.
16. Shay S, Tutuian R, Sifrim D etal. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004; 99 (6): 1037-43.
17. Zerbib F, des Varannes S B, Roman S etal. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 2005; 22: 1011-21.
18. Zentilin P, Iiritano E, Dulbecco P etal. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis 2006; 38 (4): 226-32.
19. del Genio G, Tolone S, del Genio F etal. Prospective assessment of patient selection for antireflux surgery by combined multichannel intraluminal impedance pH monitoring. J Gastrointest Surg 2008; 12: 1491-6.
20. Frazzoni M, Conigliaro R, Melotti G. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring. Dig Dis Sci 2011; 56 (4): 1099-106.
21. Johnson L F, DeMeester T R. Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol 1986; 8 (Suppl 1): 52-8.
22. Kahrilas P J, Quigley E M. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110 (6): 1982-96.
23. Johnson L F, Demeester T R. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974; 62 (4): 325-32.
24. Pandolfino J E, Richter J E, Ours T, Guardino J M, Chapman J, Kahrilas P J. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003; 98 (4): 740-9.
25. Wenner J, Johnsson F, Johansson J, Oberg S. Wireless oesophageal pH monitoring: feasibility, safety and normal values in healthy subjects. Scand J Gastroenterol 2005; 40 (7): 768-74.
26. Vitale G C, Cheadle W G, Sadek S, Michel M E, Cuschieri A. Computerized 24-hour ambulatory esophageal pH monitoring and esophagogastroduodenoscopy in the reflux patient. A comparative study. Ann Surg 1984; 200 (6): 724-8.
27. Mattioli S, Pilotti V, Spangaro M etal. Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci 1989; 34 (1): 71-8.
28. Baldi F, Ferrarini F, Longanesi A, Bersani G. Ambulatory 24-hour oesophageal pH monitoring in normal subjects: a multicentre study in Italy. G.I.S.M.A.D. GOR Study Group. Ital J Gastroenterol 1991; 23 (8): 477-80.
29. Richter J E, Bradley L A, DeMeester T R, Wu W C. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992; 37 (6): 849-56.
30. Hirano I, Richter J E. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007; 102 (3): 668-85.
31. Fass R, Fennerty M B, Johnson C, Camargo L, Sampliner R E. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease. J Clin Gastroenterol 1999; 28 (1): 36-9.
32. Fass R, Ofman J J, Sampliner R E, Camargo L, Wendel C, Fennerty M B. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000; 14 (4): 389-96.
33. Charbel S, Khandwala F, Vaezi M F. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 2005; 100 (2): 283-9.
34. Ahlawat S K, Novak D J, Williams D C, Maher K A, Barton F, Benjamin S B. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system. J Clin Gastroenterol 2006; 40 (1): 20-4.
35. Ward E M, Devault K R, Bouras E P etal. Successful oesophageal pH monitoring with a catheter-free system. Aliment Pharmacol Ther 2004; 19 (4): 449-54.
36. Scarpulla G, Camilleri S, Galante P, Manganaro M, Fox M. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol 2007; 102 (12): 2642-7.
37. Hirano I, Zhang Q, Pandolfino J E, Kahrilas P J. Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2005; 3: 1083-8.
38. Clouse R E, Prakash C, Haroian L. Symptom association tests are improved by the extended ambulatory pH recording time with Bravo capsule. Gastroenterology 2003; 124 (4): Abstract Digestive Disease Week.
39. Wenner J, Johnsson F, Johansson J, Oberg S. Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial. Am J Gastroenterol 2007; 102 (2): 239-45.
40. Croffie J M, Fitzgerald J F, Molleston J P etal. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years. J Pediatr Gastroenterol Nutr 2007; 45 (5): 559-63.
41. Pandolfino J, Zhang Q, Schreiner M, Ghosh S, Roth M, Kahrilas P J. Acid reflux event detection using the BravoTM wireless vs the SlimlineTM catheter pH systems: why are the numbers so different? Gut 2005; 54 (12): 1687-92.
42. Lacy B E, O'Shana T, Hynes M etal. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor. Am J Gastroenterol 2007; 102 (1): 24-32.